139 related articles for article (PubMed ID: 20054309)
1. Use of infliximab in pregnancy.
Mahadevan U; Kane S
Am J Gastroenterol; 2010 Jan; 105(1):219; author reply 219-20. PubMed ID: 20054309
[No Abstract] [Full Text] [Related]
2. Use of infliximab in particular clinical settings: management based on current evidence.
Papa A; Mocci G; Bonizzi M; Felice C; Andrisani G; De Vitis I; Guidi L; Gasbarrini A
Am J Gastroenterol; 2009 Jun; 104(6):1575-86. PubMed ID: 19491875
[TBL] [Abstract][Full Text] [Related]
3. Infliximab anaphylaxis in siblings.
Teich N
Inflamm Bowel Dis; 2011 Aug; 17(8):E108. PubMed ID: 21567666
[No Abstract] [Full Text] [Related]
4. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use.
Tiemi J; Komati S; Sdepanian VL
J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321
[TBL] [Abstract][Full Text] [Related]
5. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
Wedekind S
MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
[No Abstract] [Full Text] [Related]
6. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
[TBL] [Abstract][Full Text] [Related]
7. [Use of TNFalpha antibodies in treatment of inflammatory bowel disease].
Martinsen TC; Herter R; Dybdahl JH; Waldum HL
Tidsskr Nor Laegeforen; 2010 Feb; 130(3):273-7. PubMed ID: 20160771
[TBL] [Abstract][Full Text] [Related]
8. [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
Stiefelhagen P
MMW Fortschr Med; 2011 Dec; 153(49-50):20-1. PubMed ID: 22308586
[No Abstract] [Full Text] [Related]
9. Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal.
Regadas FS; Pinto RA; Murad-Regadas SM; Canedo JA; Leal M; Nogueras JJ; Wexner SD
Colorectal Dis; 2011 May; 13(5):555-60. PubMed ID: 20070344
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory bowel diseases--new therapeutic options].
Herrlinger K; Stange EF
Med Klin (Munich); 2008 Feb; 103(2):90-101; quiz 102-3. PubMed ID: 18270665
[No Abstract] [Full Text] [Related]
11. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
12. Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis.
Aratari A; Margagnoni G; Koch M; Papi C
J Crohns Colitis; 2011 Jun; 5(3):262. PubMed ID: 21575893
[No Abstract] [Full Text] [Related]
13. Immunogenicity of infliximab: how to handle the problem?
Baert F; De Vos M; Louis E; Vermeire S;
Acta Gastroenterol Belg; 2007; 70(2):163-70. PubMed ID: 17715629
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.
Lee TW; Fedorak RN
Gastroenterol Clin North Am; 2010 Sep; 39(3):543-57. PubMed ID: 20951917
[TBL] [Abstract][Full Text] [Related]
15. Low trough serum infliximab and antibodies to infliximab in smokers.
Kong JY; Bundell C; Pawlik J; Hollingsworth P; Forbes G
Inflamm Bowel Dis; 2013 Mar; 19(3):E35-6. PubMed ID: 22345044
[No Abstract] [Full Text] [Related]
16. Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease.
Grosen A; Julsgaard M; Kelsen J; Christensen LA
J Crohns Colitis; 2014 Feb; 8(2):175-6. PubMed ID: 24090905
[No Abstract] [Full Text] [Related]
17. Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease.
Steenholdt C; Bendtzen K; Brynskov J; Thomsen OØ; Ainsworth MA
Scand J Gastroenterol; 2011 Mar; 46(3):310-8. PubMed ID: 21087119
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience.
Sandborn WJ
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S232-3. PubMed ID: 18816658
[No Abstract] [Full Text] [Related]
19. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
Moum B
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
[No Abstract] [Full Text] [Related]
20. Is there a role for infliximab in severe ulcerative colitis?: the European experience.
Kohn A
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S234-5. PubMed ID: 18816780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
